• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDIVANCE, INC. ¿ 1725056 ARCTIC SUN® TEMPERATURE MANAGEMENT SYSTEM, ARCTICGEL¿ PADS; ARCTIC GEL PADS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDIVANCE, INC. ¿ 1725056 ARCTIC SUN® TEMPERATURE MANAGEMENT SYSTEM, ARCTICGEL¿ PADS; ARCTIC GEL PADS Back to Search Results
Catalog Number 317-07-02
Device Problems Fluid/Blood Leak (1250); Patient Device Interaction Problem (4001)
Patient Problems Burn(s) (1757); Skin Tears (2516); Blister (4537)
Event Date 11/22/2022
Event Type  Injury  
Event Description
It was reported that when using the bard hypothermia arctic gel pad, the patch failed and burned a patient, thus requiring medical intervention.As per follow up information received via email on 29nov2022, the patient received a 9cm x 9cm x 0.1 cm burn with unroofed blister.The patient condition before applying pads was supervised by representative or cardiac arrest and met criteria for targeted temperature management (ttm) and placed on therapy patient had no open areas or wounds prior to initiation of therapy.Thigh pad was discontinued due to injury, remaining pads and therapy discontinued one hour later with treatment goal met.Patient seen appropriate consults, therapy discontinued, wound treated by care consult.In critical care primary physician evaluation patient treated with pad removal, and discontinued area cleansed and silvadene applied followed by telfa and dressing pat with lot number # nggs2684.The date of event was on (b)(6) 2022.It was noted that the weight of the patient to be 67years old female with height 160cm (5'3") with weight 57.1 kg (125 lbs and 14oz).Faulty pad was saved.
 
Manufacturer Narrative
The investigation is still in progress.Once the investigation is complete a supplemental report will be filed.
 
Manufacturer Narrative
The reported event was unconfirmed as no leakage occurred during sample evaluation.Visual evaluation noted received 1 arctic gel pad left thigh with no original packaging.Visual inspection of the pad surface noted no obvious visible defects such as cuts or tears in the foam.Visual inspection of the clear connectors noted no visible chips or deformities at the ends of all connectors.Visual inspection of the tubing for all the pads noted no kinks.Further testing required.Functional evaluation noted flow test was conducted.No leakage occurred during the duration of the test therefore product meets specifications.The device history record was reviewed and found nothing that could have caused or contributed to the reported event.Labelling review is not required as the reported event is unconfirmed.Correction: d, f, g, h.H11: section a through f - the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : the actual/suspected device was inspected.
 
Event Description
It was reported that when using the bard hypothermia arctic gel pad, the patch failed and burned a patient, thus requiring medical intervention.Per follow-up information received via email on 29nov2022, the patient received a 9 cm x 9 cm x 0.1 cm burn with unroofed blister.The patient condition before applying pads was supervised by representative or cardiac arrest and met criteria for targeted temperature management (ttm) and placed on therapy patient had no open areas or wounds prior to initiation of therapy.Thigh pad was discontinued due to injury, remaining pads and therapy discontinued one hour later with treatment goal met.Patient seen appropriate consults, therapy discontinued, wound treated by care consult.In critical care primary physician evaluation, patient treated with pad removal, and discontinued area cleansed and silvadene applied followed by telfa and dressing pat with lot number # nggs2684.The date of event was on 22nov2022.It was noted that the weight of the patient to be 67 years old female with height 160 cm (5'3") with weight 57.1 kg (125 lbs and 14oz).Faulty pad was saved.Per additional information received via form with sample returned on 12dec2022, arctic gel on pad release from usual dot matrix into one patch.The patch then leaked water onto the patient thigh during the warming phase of target temperature management.Patient peeled surface or burn from patch area.Temperature set at 37.4c.The patient had injury to skin requiring treatment and wound consult.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCTIC SUN® TEMPERATURE MANAGEMENT SYSTEM, ARCTICGEL¿ PADS
Type of Device
ARCTIC GEL PADS
Manufacturer (Section D)
MEDIVANCE, INC. ¿ 1725056
321 s taylor ave
suite 200
louisville 80027
Manufacturer (Section G)
MEDIVANCE, INC. ¿ 1725056
321 s taylor ave
suite 200
louisville 80027
Manufacturer Contact
xeeroy rada
8195 industrial blvd
covington 30014
7707846100
MDR Report Key15958590
MDR Text Key305248531
Report Number1018233-2022-09452
Device Sequence Number1
Product Code DWJ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K142702
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional,User Facility
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/31/2024
Device Catalogue Number317-07-02
Device Lot NumberNGGS2684
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/23/2022
Initial Date FDA Received12/12/2022
Supplement Dates Manufacturer Received04/03/2023
Supplement Dates FDA Received04/04/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/27/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age67 YR
Patient SexFemale
Patient Weight57 KG
-
-